Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Yes, Wegovy is administered as a subcutaneous injection—a shot delivered just under the skin once per week. This delivery method allows semaglutide to enter your bloodstream gradually, triggering appetite suppression and improved blood sugar control. Understanding how this injection works can help you decide if it's the right option for your weight loss journey.
How Subcutaneous Injections Deliver Semaglutide
Subcutaneous injections place medication into the fatty tissue layer beneath your skin, where it absorbs slowly over time. This location—typically the abdomen, thigh, or upper arm—allows semaglutide to reach your bloodstream consistently throughout the week. The slow-release design means you inject only once per week, rather than taking a daily pill, which improves adherence for many patients.
The semaglutide molecule then travels to your brain and gut, where it binds to GLP-1 receptors. These receptors signal satiety (fullness), reduce hunger-driving hormones, and slow stomach emptying. Clinical trials show this mechanism leads to 15-22% body weight reduction over 68 weeks in patients with obesity.
Weekly Injection Schedule and Dosing Strategy
Wegovy and similar semaglutide therapies follow a gradual dose-escalation protocol starting at 0.25 mg per week. Your healthcare provider increases the dose every 4 weeks—moving to 0.5 mg, then 1.0 mg, 1.7 mg, and up to 2.4 mg—based on your tolerance and weight loss response. This stepwise approach minimizes nausea and gastrointestinal side effects that some patients experience early in treatment.
PlexusDx compounded semaglutide injections offer the same evidence-based dosing flexibility at a flat monthly rate. Your dose may need to go up. Your price won't. This pricing model removes the barrier of escalating out-of-pocket costs as your treatment progresses, making long-term weight management more affordable and predictable.
Subcutaneous Injection Technique and Self-Administration
Most patients learn to self-inject subcutaneously at home using a pre-filled pen or syringe. The needle is typically very small (27-29 gauge), and injection sites rotate weekly to prevent lipohypertrophy (fatty lumps under the skin). Patient education and technique training reduce injection anxiety and ensure consistent drug delivery week to week.
PlexusDx provides clear injection instructions and supports telehealth consultations with licensed providers who can observe your technique and answer questions remotely. Many patients report that after the first two or three injections, the process becomes routine and requires less than one minute per week.
PlexusDx Compounded Semaglutide vs. Brand-Name Alternatives
Brand-name Wegovy is an FDA-approved injectable semaglutide, but its high list price ($1,300+/month) puts it out of reach for many patients without insurance coverage. PlexusDx compounds pharmaceutical-grade semaglutide in licensed 503A compounding pharmacies, meeting the same purity and potency standards as brand products. Compounded semaglutide injections from PlexusDx start at $149/month across all 50 states with no membership fee or insurance requirement.
Both brand and compounded options use subcutaneous injection delivery and activate the same GLP-1 receptor pathway. The key difference is accessibility and cost. PlexusDx serves patients who want personalized, affordable weight loss therapy and may benefit from the Precision Peptide Genetic Test ($99 add-on) to identify which GLP-1 pathway variant (like GLP1R rs6923761) predicts your individual response to semaglutide.
Who Benefits Most from Subcutaneous Semaglutide Injections
Patients with a BMI ≥30 or ≥27 with weight-related comorbidities (type 2 diabetes, hypertension, heart disease) show the strongest weight loss and metabolic benefits from semaglutide injections. Weekly dosing also suits people who prefer not to take a daily pill or who have difficulty swallowing tablets. The gradual dose escalation allows most patients to tolerate the medication without severe side effects.
Your genetic profile may influence how well you respond to semaglutide. PlexusDx Precision Peptide Genetic Test maps variants in the GLP1R, GIPR, FTO, and MC4R genes—pathways directly involved in appetite regulation and weight response. Understanding your genetic predispositions helps PlexusDx and your provider optimize your personalized treatment plan from month one.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is a subcutaneous injection painful?
Subcutaneous needles are very fine (27-29 gauge) and most patients report minimal to no pain—often described as a slight pinch. The needle enters only the fatty layer under skin, not muscle, so discomfort is brief. After 2-3 injections, most patients feel confident and experience minimal anxiety.
How does the subcutaneous injection work differently than an oral pill?
Subcutaneous injections bypass the digestive system, allowing semaglutide to enter the bloodstream directly and maintain steady levels for a full week. Oral semaglutide must be taken daily on an empty stomach and requires specific timing to ensure absorption. The weekly injection offers superior convenience and more consistent therapeutic levels.
Can I switch from Wegovy to PlexusDx compounded semaglutide?
Yes. Both use the same active ingredient and subcutaneous delivery method. PlexusDx compounded semaglutide from licensed 503A pharmacies meets the same pharmaceutical standards. Switching can reduce your monthly cost from $1,300+ to $149/month while maintaining the same clinical approach.
What are the common side effects of subcutaneous semaglutide?
Early side effects include nausea, vomiting, and constipation—most common in the first 4 weeks. Gradual dose escalation minimizes these effects. Serious side effects are rare but include pancreatitis and gallbladder issues; report severe abdominal pain to your provider immediately. Most patients develop tolerance within 8-12 weeks.
How does PlexusDx personalize semaglutide therapy with genetic testing?
PlexusDx Precision Peptide Genetic Test identifies your variants in GLP1R, GIPR, FTO, and MC4R genes that influence semaglutide response and appetite biology. This genetic insight helps your provider predict tolerability, optimize dosing speed, and identify if combination therapy (dual GLP-1/GIP agonist) may work better for your unique biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Do You Know If Wegovy Is Working? Tracking Your Weight Loss Success
Navigating Weight Management: Can You Take Ozempic After Gastric Bypass?